 |
Previous Article | Next Article 
The Journal of Neuroscience, March 1, 2003, 23(5):1949
Serum Transthyretin Monomer as a Possible Marker of Blood-to-CSF
Barrier Disruption
Nicola
Marchi1,
Vince
Fazio1,
Luca
Cucullo1,
Kelly
Kight1,
Thomas
Masaryk2, 3,
Gene
Barnett3, 5,
Michael
Volgelbaum3, 5,
Michael
Kinter4,
Peter
Rasmussen3,
Marc R.
Mayberg1, 3, 5, and
Damir
Janigro1, 3, 4, 5
1 Division of Cerebrovascular Research, Departments of
2 Radiology, 3 Neurosurgery, 4 Cell
Biology and 5 Brain Tumor Institute, Cleveland Clinic
Foundation, Cleveland, Ohio 44196
The CNS is shielded from systemic influences by two separate
barriers, the blood-brain barrier (BBB) and the blood-to-CSF barrier.
Failure of either barrier bears profound significance in the etiology
and diagnosis of several neurological diseases. Furthermore, selective
opening of BBB tight junctions provides an opportunity for delivery of
otherwise BBB impermeant drugs. Peripheral assessment of BBB opening
can be achieved by detection in blood of brain-specific proteins that
extravasate when these endothelial junctions are breached. We developed
a proteomic approach to discover clusters of CNS-specific
proteins with extravasation into serum that correlates with BBB
openings. Protein profiles from blood samples obtained from patients
undergoing iatrogenic BBB disruption (BBBD) with intra-arterial
hyperosmotic mannitol were compared with pre-BBB opening serum. A low
molecular weight protein (14 kDa) identified by mass spectroscopy as
transthyretin (TTR) consistently correlated with BBBD. Protein gel
electrophoresis and immunodetection confirmed that TTR was indeed
extravasated in its monomeric form when CNS barriers were breached. The
time course of TTR extravasation was compared with release from the brain of another BBB integrity marker, S-100 (11 kDa). Kinetic analysis revealed that the appearance of S-100 , presumably
originating from perivascular astrocytic end feet, preceded
extravasation of TTR by several minutes. Because TTR is localized
primarily in choroid plexus and, as a soluble monomer, in CSF, we
concluded that although S-100 is a marker of BBB integrity, TTR
instead may be a peripheral tracer of blood-to-cerebrospinal barrier.
Key words:
MRI; neurological disorders; choroid plexus; cerebral blood flow; neurodegeneration; neuroinflammation
Copyright © 2003 Society for Neuroscience 0270-6474/03/2351949-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
V. Lehmensiek, S. Sussmuth, G. Tauscher, J. Brettschneider, S. Felk, F. Gillardon, and H. Tumani
Cerebrospinal fluid proteome profile in multiple sclerosis
Multiple Sclerosis,
August 1, 2007;
13(7):
840 - 849.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-C. TSAI, Y.-C. LIU, S. S.-J. LEE, E.-R. CHEN, and C.-M. YEN
VASCULAR ENDOTHELIAL GROWTH FACTOR IS ASSOCIATED WITH BLOOD BRAIN BARRIER DYSFUNCTION IN EOSINOPHILIC MENINGITIS CAUSED BY ANGIOSTRONGYLUS CANTONENSIS INFECTION
Am J Trop Med Hyg,
March 1, 2007;
76(3):
592 - 595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gorogh, P. Rudolph, J. E. Meyer, J. A. Werner, B. M. Lippert, and S. Maune
Separation of {beta}2-Transferrin by Denaturing Gel Electrophoresis to Detect Cerebrospinal Fluid in Ear and Nasal Fluids
Clin. Chem.,
September 1, 2005;
51(9):
1704 - 1710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fazio, S. K. Bhudia, N. Marchi, B. Aumayr, and D. Janigro
Peripheral detection of S100{beta} during cardiothoracic surgery: what are we really measuring?
Ann. Thorac. Surg.,
July 1, 2004;
78(1):
46 - 52.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|